CROSSJECT |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.02 EUR | +0.50% |
|
-6.48% | -59.36% |
| May. 03 | Crossject: praised for extended agreement on Zepizure | CF |
| May. 02 | Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CROSSJECT | Drug Delivery Systems | +0.50% | -6.48% | -59.36% | -37.85% | +7.73% | 83.48M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ALCJ Stock
- Charts Crossject
- Comparison Chart